ORPP logo

Pharmacogenetics of Breast Cancer : (Record no. 67046)

MARC details
000 -LEADER
fixed length control field 03457nam a22004573i 4500
001 - CONTROL NUMBER
control field EBC3059666
003 - CONTROL NUMBER IDENTIFIER
control field MiAaPQ
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20240729124451.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m o d |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr cnu||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 240724s2008 xx o ||||0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781420052947
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 9781420052930
035 ## - SYSTEM CONTROL NUMBER
System control number (MiAaPQ)EBC3059666
035 ## - SYSTEM CONTROL NUMBER
System control number (Au-PeEL)EBL3059666
035 ## - SYSTEM CONTROL NUMBER
System control number (CaPaEBR)ebr10231553
035 ## - SYSTEM CONTROL NUMBER
System control number (CaONFJC)MIL173192
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)922955756
040 ## - CATALOGING SOURCE
Original cataloging agency MiAaPQ
Language of cataloging eng
Description conventions rda
-- pn
Transcribing agency MiAaPQ
Modifying agency MiAaPQ
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RC280.B8P43 2008
082 0# - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 616.99/449
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Leyland-Jones, Brian.
245 10 - TITLE STATEMENT
Title Pharmacogenetics of Breast Cancer :
Remainder of title Towards the Individualization of Therapy.
250 ## - EDITION STATEMENT
Edition statement 1st ed.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture New York :
Name of producer, publisher, distributor, manufacturer Taylor & Francis Group,
Date of production, publication, distribution, manufacture, or copyright notice 2008.
264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice ©2008.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (351 pages)
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Cover -- Half Title -- Title Page -- Copyright Page -- Preface -- Acknowledgments -- Table of Contents -- Contributors -- 1: Pharmacogenetics of Breast Cancer: Toward the Individualization of Therapy -- 2: Pharmacology, Pharmacogenetics, and Pharmacoepidemiology: Three P's of Individualized Therapy -- 3: Role of Genetic Variability in Breast Cancer Treatment Outcomes -- 4: The Role of Epigenetics in Breast Cancer: Implications for Diagnosis, Prognosis, and Treatment -- 5: Comparative Genomic Hybridization and Copy Number Abnormalities in Breast Cancer -- 6: Gene Expression Profiling as an Emerging Diagnostic Tool to Personalize Chemotherapy Selection for Early Stage Breast Cancer -- 7: Gene Expression-Based Predictors of Prognosis and Response to Chemotherapy in Breast Cancer -- 8: Utilization of Genomic Signatures for Personalized Treatment of Breast Cancer -- 9: Personalized Medicine by the Use of Microarray Gene Expression Profiling -- 10: Predictive Markers for Targeted Breast Cancer Treatment -- 11: Circulating Tumor Cells in Individualizing Breast Cancer Therapy -- 12: Individualization of Endocrine Therapy in Breast Cancer -- 13: TAILORx: Rationale for the Study Design -- 14: Taking Prognostic Signatures to the Clinic -- 15: Tissue is the Issue -- 16: Acquisition and Preservation of Tissue for Microarray Analysis -- 17: Tapping into the Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Gold Mine for Individualization of Breast Cancer Treatment -- 18: Breast Cancer Stem Cells and Their Niche: Lethal Seeds in Lethal Soil -- 19: Molecular Imaging in Individualized Cancer Management -- 20: Cancer Nanotechnology for Molecular Profiling and Individualized Therapy -- Index.
588 ## - SOURCE OF DESCRIPTION NOTE
Source of description note Description based on publisher supplied metadata and other sources.
590 ## - LOCAL NOTE (RLIN)
Local note Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Breast -- Cancer -- Genetic aspects.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Breast -- Cancer -- Chemotherapy.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pharmacogenetics.
655 #4 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Print version:
Main entry heading Leyland-Jones, Brian
Title Pharmacogenetics of Breast Cancer
Place, publisher, and date of publication New York : Taylor & Francis Group,c2008
International Standard Book Number 9781420052930
797 2# - LOCAL ADDED ENTRY--CORPORATE NAME (RLIN)
Corporate name or jurisdiction name as entry element ProQuest (Firm)
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=3059666">https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=3059666</a>
Public note Click to View

No items available.

© 2024 Resource Centre. All rights reserved.